FBXL17
Disease associated variation - ClinVar
Allele IDTypeNameRS#dbSNPPhenotype IDsChromosomeStartStopReferenceAlternate
157522copy number lossGRCh38/hg38 5q21.3(chr5:108021878-108339280)x1-1-5107357579107674981nana
157522copy number lossGRCh38/hg38 5q21.3(chr5:108021878-108339280)x1-1-5108021878108339280nana
157522copy number lossGRCh38/hg38 5q21.3(chr5:108021878-108339280)x1-1-5107385478107702880nana
Disease associated variation - GWASdb
ChrPosSNP ID(dbSNP 142)RefAltOri SNP IDP-valueDrug NameDrug AnnoGWAS TraitHPO IDDO IDAATypeTrait or Drug
5107397314rs7728371GTrs77283713.57E-06DEXTROAMPHETAMINEPLACEBOS|CADHERINS|H-CADHERIN|PREGNANOLONEResponse to amphetaminesHPOID:0000707DOID:670GintronGWASdb_drug
5107401451rs11242661CTrs112426611.00E-06DEXTROAMPHETAMINEPLACEBOS|CADHERINS|H-CADHERIN|PREGNANOLONEResponse to amphetaminesHPOID:0000707DOID:670CintronGWASdb_drug
5107402223rs10035292CTrs100352924.22E-06DEXTROAMPHETAMINEPLACEBOS|CADHERINS|H-CADHERIN|PREGNANOLONEResponse to amphetaminesHPOID:0000707DOID:670TintronGWASdb_drug
5107410205rs286794GTrs2867945.80E-06DEXTROAMPHETAMINEPLACEBOS|CADHERINS|H-CADHERIN|PREGNANOLONEResponse to amphetaminesHPOID:0000707DOID:670AintronGWASdb_drug
5107412941rs158415CTrs1584159.32E-06DEXTROAMPHETAMINEPLACEBOS|CADHERINS|H-CADHERIN|PREGNANOLONEResponse to amphetaminesHPOID:0000707DOID:670AintronGWASdb_drug
5107504326rs10063866TCrs100638665.34E-06DEXTROAMPHETAMINEPLACEBOS|CADHERINS|H-CADHERIN|PREGNANOLONEResponse to amphetaminesHPOID:0000707DOID:670CintronGWASdb_drug
5107511609rs6883082TCrs68830824.82E-06DEXTROAMPHETAMINEPLACEBOS|CADHERINS|H-CADHERIN|PREGNANOLONEResponse to amphetaminesHPOID:0000707DOID:670TintronGWASdb_drug
5107512145rs6596770CTrs65967704.60E-06DEXTROAMPHETAMINEPLACEBOS|CADHERINS|H-CADHERIN|PREGNANOLONEResponse to amphetaminesHPOID:0000707DOID:670CintronGWASdb_drug
5107512536rs6596771GArs65967714.54E-06DEXTROAMPHETAMINEPLACEBOS|CADHERINS|H-CADHERIN|PREGNANOLONEResponse to amphetaminesHPOID:0000707DOID:670GintronGWASdb_drug
5107513703rs10463586TGrs104635863.66E-06DEXTROAMPHETAMINEPLACEBOS|CADHERINS|H-CADHERIN|PREGNANOLONEResponse to amphetaminesHPOID:0000707DOID:670TintronGWASdb_drug
5107514366rs7713705GCrs77137055.42E-06DEXTROAMPHETAMINEPLACEBOS|CADHERINS|H-CADHERIN|PREGNANOLONEResponse to amphetaminesHPOID:0000707DOID:670GintronGWASdb_drug
5107521134rs286767TCrs2867676.53E-06DEXTROAMPHETAMINEPLACEBOS|CADHERINS|H-CADHERIN|PREGNANOLONEResponse to amphetaminesHPOID:0000707DOID:670GintronGWASdb_drug
5107561614rs2122158TCrs21221589.19E-06DEXTROAMPHETAMINEPLACEBOS|CADHERINS|H-CADHERIN|PREGNANOLONEResponse to amphetaminesHPOID:0000707DOID:670TintronGWASdb_drug
5107196976rs1865015GArs18650153.10E-05Insulin ResistanceHPOID:0000855DOID:9352CUTR-3GWASdb_trait
5107199977rs11740286TCrs117402862.30E-06Urinary metabolitesHPOID:0000079DOID:557TintronGWASdb_trait
5107202929rs6596759CArs65967593.10E-05Insulin ResistanceHPOID:0000855DOID:9352CintronGWASdb_trait
5107205182rs7708343GArs77083439.75E-04Obesity (extreme)HPOID:0001513DOID:9970GintronGWASdb_trait
5107233155rs7726739CGrs77267397.30E-07Urinary metabolitesHPOID:0000079DOID:557CintronGWASdb_trait
5107233791rs10069340GArs100693409.76E-04Alcohol dependenceHPOID:0000707DOID:0050741G,AintronGWASdb_trait
5107263580rs11743737TCrs117437378.77E-05Coronary heart diseaseHPOID:0001677DOID:3393TintronGWASdb_trait
5107274258rs7719403CTrs77194031.32E-04Smoking cessationHPOID:0000707DOID:0050742TintronGWASdb_trait
5107281621rs10070308CTrs100703084.00E-06Bipolar disorder (body mass index interaction)HPOID:0007302DOID:3312TintronGWASdb_trait
5107282348rs72795979TCrs727959793.00E-06Bipolar disorder (body mass index interaction)HPOID:0007302DOID:3312CintronGWASdb_trait
5107282349rs72795980CTrs727959802.00E-06Bipolar disorder (body mass index interaction)HPOID:0007302DOID:3312TintronGWASdb_trait
5107300655rs885624TCrs8856245.19E-04Nicotine dependenceHPOID:0000707DOID:0050742AintronGWASdb_trait
5107310203rs11744308ATrs117443086.69E-04Nicotine dependenceHPOID:0000707DOID:0050742AintronGWASdb_trait
5107320230rs10793832TCrs107938328.13E-05Nicotine dependenceHPOID:0000707DOID:0050742TintronGWASdb_trait
5107320882rs13157529GTrs131575295.00E-05Response to lithium treatment in bipolar disorderHPOID:0007302DOID:3312GintronGWASdb_trait
5107323866rs12514413TCrs125144134.30E-04Nicotine dependenceHPOID:0000707DOID:0050742TintronGWASdb_trait
5107348043rs723397CTrs7233973.00E-04Type 2 diabetesHPOID:0005978DOID:9352CintronGWASdb_trait
5107395234rs288144GTrs2881447.79E-04Type 2 diabetesHPOID:0005978DOID:9352CintronGWASdb_trait
5107397314rs7728371GTrs77283713.57E-06Response to amphetaminesHPOID:0000707DOID:670GintronGWASdb_trait
5107400505rs288139GArs2881391.00E-06Eye colorHPOID:0000478DOID:240CintronGWASdb_trait
5107401451rs11242661CTrs112426611.00E-06Response to amphetaminesHPOID:0000707DOID:670CintronGWASdb_trait
5107402223rs10035292CTrs100352924.22E-06Response to amphetaminesHPOID:0000707DOID:670TintronGWASdb_trait
5107402938rs286751CTrs2867512.10E-05Electrocardiographic traits and heart rate variabilityHPOID:0003115|HPOID:0011675DOID:10273AintronGWASdb_trait
5107405476rs289227CGrs2892276.71E-04Type 2 diabetesHPOID:0005978DOID:9352GintronGWASdb_trait
5107410205rs286794GTrs2867945.80E-06Response to amphetaminesHPOID:0000707DOID:670AintronGWASdb_trait
5107412941rs158415CTrs1584159.32E-06Response to amphetaminesHPOID:0000707DOID:670AintronGWASdb_trait
5107417744rs11242662TArs112426621.50E-05Urinary metabolitesHPOID:0000079DOID:557TintronGWASdb_trait
5107447121rs40062GArs400628.35E-04Suicide attempts in bipolar disorderHPOID:0007302DOID:3312TintronGWASdb_trait
5107458637rs286809GArs2868095.28E-04Type 2 diabetesHPOID:0005978DOID:9352CintronGWASdb_trait
5107459529rs12652687TCrs126526877.76E-05Body Mass IndexHPOID:0001507DOID:9970TintronGWASdb_trait
5107466006rs34430ACrs344308.43E-04Suicide attempts in bipolar disorderHPOID:0007302DOID:3312GintronGWASdb_trait
5107467243rs40072TArs400729.49E-04Suicide attempts in bipolar disorderHPOID:0007302DOID:3312TintronGWASdb_trait
5107482854rs286797CTrs2867974.70E-04Statin-induced myopathyHPOID:0001637DOID:0080000AintronGWASdb_trait
5107485161rs12515105CArs125151055.55E-05Orofacial cleftsHPOID:0000202DOID:0050567CintronGWASdb_trait
5107500144rs34424TCrs344246.71E-04Type 2 diabetesHPOID:0005978DOID:9352AintronGWASdb_trait
5107504326rs10063866TCrs100638665.34E-06Response to amphetaminesHPOID:0000707DOID:670CintronGWASdb_trait
5107511609rs6883082TCrs68830824.82E-06Response to amphetaminesHPOID:0000707DOID:670TintronGWASdb_trait
5107512145rs6596770CTrs65967704.60E-06Response to amphetaminesHPOID:0000707DOID:670CintronGWASdb_trait
5107512536rs6596771GArs65967714.54E-06Response to amphetaminesHPOID:0000707DOID:670GintronGWASdb_trait
5107513703rs10463586TGrs104635863.66E-06Response to amphetaminesHPOID:0000707DOID:670TintronGWASdb_trait
5107514366rs7713705GCrs77137055.42E-06Response to amphetaminesHPOID:0000707DOID:670GintronGWASdb_trait
5107521134rs286767TCrs2867676.53E-06Response to amphetaminesHPOID:0000707DOID:670GintronGWASdb_trait
5107531302rs286763TCrs2867632.68E-06Statin-induced myopathyHPOID:0001637DOID:0080000GintronGWASdb_trait
5107534886rs2966821ACrs29668212.64E-04Statin-induced myopathyHPOID:0001637DOID:0080000GintronGWASdb_trait
5107557861rs13187816TCrs131878162.53E-05HDL cholesterolHPOID:0003107DOID:14502|DOID:1461|DOID:3393TintronGWASdb_trait
5107561614rs2122158TCrs21221589.19E-06Response to amphetaminesHPOID:0000707DOID:670TintronGWASdb_trait
5107630494rs10045002CArs100450029.58E-04Suicide attempts in bipolar disorderHPOID:0007302DOID:3312AintronGWASdb_trait
5107671932rs2966833GArs29668338.07E-04Suicide attempts in bipolar disorderHPOID:0007302DOID:3312AintronGWASdb_trait
5107676321rs989001GArs9890015.81E-04Nicotine dependenceHPOID:0000707DOID:0050742GintronGWASdb_trait
5107684324rs1862195CTrs18621951.44E-05HDL cholesterolHPOID:0003107DOID:14502|DOID:1461|DOID:3393TintronGWASdb_trait
5107684324rs1862195CTrs18621958.96E-05CholesterolHPOID:0003107DOID:2349|DOID:3393|DOID:3146TintronGWASdb_trait
5107687616rs12521975ATrs125219759.07E-04Lymphocyte countsHPOID:0004332|HPOID:0002665DOID:2841|DOID:1240|DOID:0060058|DOID:614|DOID:1287AintronGWASdb_trait
Disease associated variation - OMIM
Ensembl_gene_ID Approved Gene Symbol MIM Number
ENSG00000145743.15 FBXL17 609083